Your search returned 4 results.

Results
	1.	Time-varying feature selection for longitudinal analysis. [electronic resource] by Xue, Lan Shu, Xinxin Shi, Peibei Wu, Colin O Qu, Annie Producer: 20210125 In: Statistics in medicine vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study. [electronic resource] by Bauml, Joshua Seiwert, Tanguy Y Pfister, David G Worden, Francis Liu, Stephen V Gilbert, Jill Saba, Nabil F Weiss, Jared Wirth, Lori Sukari, Ammar Kang, Hyunseok Gibson, Michael K Massarelli, Erminia Powell, Steven Meister, Amy Shu, Xinxin Cheng, Jonathan D Haddad, Robert Producer: 20170810 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study. [electronic resource] by Atkins, Michael B Hodi, F Stephen Thompson, John A McDermott, David F Hwu, Wen-Jen Lawrence, Donald P Dawson, Nancy A Wong, Deborah J Bhatia, Shailender James, Marihella Jain, Lokesh Robey, Seth Shu, Xinxin Homet Moreno, Blanca Perini, Rodolfo F Choueiri, Toni K Ribas, Antoni Producer: 20191218 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial. [electronic resource] by Long, Georgina V Atkinson, Victoria Cebon, Jonathan S Jameson, Michael B Fitzharris, Bernie M McNeil, Catriona M Hill, Andrew G Ribas, Antoni Atkins, Michael B Thompson, John A Hwu, Wen-Jen Hodi, F Stephen Menzies, Alexander M Guminski, Alexander D Kefford, Richard Kong, Benjamin Y Tamjid, Babak Srivastava, Archana Lomax, Anna J Islam, Mohammed Shu, Xinxin Ebbinghaus, Scot Ibrahim, Nageatte Carlino, Matteo S Producer: 20170925 In: The Lancet. Oncology vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)